Glucagon emergency kits recalled due to loss of potency
A product complaint reported that the vial of glucagon in the kit was in liquid form instead of powder form. This could cause it to fail to treat severe hypoglycemia due to loss of potency, the FDA said.
Eli Lilly and Company is recalling one lot of its Glucagon Emergency Kit for Low Blood Sugar (glucagon for injection, 1 mg/vial; diluent for glucagon, 1-mL syringe) to the consumer level due to loss of potency, the FDA announced on Sept. 26.
A product complaint reported that the vial of glucagon in the kit was in liquid form instead of powder form and that the involved patient experienced lack of drug effect and reported subsequent seizures, according to the FDA. The liquid form of this product could fail to treat severe hypoglycemia due to loss of potency, the agency said.
A company investigation determined that the liquid in the vial could be related to the manufacturing process. The affected product lot was distributed to wholesalers and retailers nationwide.